BOOSTB4: Boost Brittle Bones Before Birth A clinical trial on pre- and/or postnatal stem cell transplantation for treatment of osteogenesis imperfecta

Cecilia on the behalf of the BOOSTB4 consortium (BOOSTB4.EU) Gotherstrom

doi:10.1530/boneabs.6.IS21BIOG

IS21BIOG

Prev Next

Section Contents Cite

Bone Abstracts (2017) 6 | DOI: 10.1530/boneabs.6.IS21BIOG

ICCBH2017 Invited Speaker Abstracts (1) (2) (2 abstracts)

BOOSTB4: Boost Brittle Bones Before Birth
A clinical trial on pre- and/or postnatal stem cell transplantation for treatment of osteogenesis imperfecta

Cecilia Götherström & Abstract

Views

Biographical Details

Cecilia Götherström

Cecilia Götherström is Associate Professor in Stem Cell Research at Karolinska Institutet and her research is in the field of perinatal regenerative medicine. She was one of the first in the world to isolate and characterize human fetal mesenchymal stem cells. Dr Götherström has developed fetal mesenchymal stem cells for prenatal and postnatal transplantation purposes and since then the cells has indeed been used clinically to treat fetuses and children suffering from severe osteogenesis imperfecta with promising results. Dr Götherström is leading an international multicentre trial to evaluate the clinical effect of mesenchymal stem cell transplantation in the treatment of severe osteogenesis imperfecta.